Preoperative PSMA-targeted PET imaging: more than just a tool for prostate cancer staging?

Alexa R Meyer¹, Steven P Rowe^{1

2}, Michael A Gorin^{1

2}

Affiliations

¹ The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
² The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Comment

Alexa R Meyer et al. BJU Int. 2019 Jul.

. 2019 Jul;124(1):2-3.

doi: 10.1111/bju.14624.

Alexa R Meyer¹, Steven P Rowe^{1

2}, Michael A Gorin^{1

2}

¹ The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
² The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

No abstract available

Comment on

Gallium-68-prostate-specific membrane antigen (⁶⁸ Ga-PSMA) positron emission tomography (PET)/computed tomography (CT) predicts complete biochemical response from radical prostatectomy and lymph node dissection in intermediate- and high-risk prostate cancer.
van Leeuwen PJ, Donswijk M, Nandurkar R, Stricker P, Ho B, Heijmink S, Wit EMK, Tillier C, van Muilenkom E, Nguyen Q, van der Poel HG, Emmett L. van Leeuwen PJ, et al. BJU Int. 2019 Jul;124(1):62-68. doi: 10.1111/bju.14506. Epub 2019 Apr 7. BJU Int. 2019. PMID: 30074667